The E2F3-oncomir-1 axis is activated in Wilms' tumor

Cancer Research

Volumn 68, Issue 11, 2008, Pages 4034-4038

  Kort, Eric J ^a,f   Farber, Leslie ^a   Tretiakova, Maria ^c   Petillo, David ^a   Furge, Kyle A ^a   Yang, Ximing J ^d   Cornelius, Albert ^b   Bin, Tean Teh ^a,e,f  

^a Van Andel Research Institute   (United States)

^b Helen Devos Pediatric Rheumatology   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

^e DIVISION OF MEDICAL ONCOLOGY   (Singapore)

^f VAN ANDEL RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; MICRORNA; ONCOMIR 1 PROTEIN; PROTEIN DERIVATIVE; RNA; TRANSCRIPTION FACTOR E2F3; UNCLASSIFIED DRUG; E2F3 PROTEIN, HUMAN; PRIMER DNA;

ARTICLE; CELL CULTURE; CONTROLLED STUDY; DEREGULATION; GENE EXPRESSION; GENOMICS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY PARENCHYMA; KIDNEY TUMOR; METASTASIS; NEPHROBLASTOMA; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN INTERACTION; QUANTITATIVE ANALYSIS; SAMPLE; VALIDATION STUDY; GENE EXPRESSION PROFILING; GENETICS; METABOLISM;

BASE SEQUENCE; DNA PRIMERS; E2F3 TRANSCRIPTION FACTOR; GENE EXPRESSION PROFILING; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY NEOPLASMS; MICRORNAS; WILMS TUMOR;

EID: 49249108314     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-08-0592     Document Type: Article

References (18)

1. Phillips JL, Hayward SW, Wang Y, et al. The consequences of chromosomal aneuploidy on gene expression profiles in a cell line model for prostate carcinogenesis. Cancer Res 2001;61:8143-9.
2. Furge KA, Kort EJ, Yang XJ, Stadler WM, Kim H, Teh BT. Gene expression profiling in kidney cancer: combining differential expression and chromosomal and pathway analyses. Clin Genitourin Cancer 2006;5:227-31.
3. Furge KA, Cheng J, Koeman J, et al. Detection of DNA-copy number changes and oncogenic signaling abnormalities from gene expression data reveals MYC activation in high-grade papillary renal cell carcinoma. Cancer Res 2007;67:3171-6.
4. Feber A, Clark J, Goodwin G, et al. Amplification and overexpression of E2F3 in human bladder cancer. Oncogene 2004;23:1627-30.
5. Foster CS, Falconer A, Dodson AR, et al. Transcription factor E2F3 overexpressed in prostate cancer independently predicts clinical outcome. Oncogene 2004;23:5871-9.
6. Cooper CS, Nicholson AG, Foster C, et al. Nuclear overexpression of the E2F3 transcription factor in human lung cancer. Lung Cancer 2006;54:155-62.
7. Woods K, Thomson JM, Hammond SM. Direct regulation of an oncogenic micro-RNA cluster by E2F transcription factors. J Biol Chem 2007;282:2130-4.
8. Hayashita Y, Osada H, Tatematsu Y, et al. A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer Res 2005;65:9628-32.
9. Dai M, Wang P, Boyd AD, et al. Evolving gene/transcript definitions significantly alter the interpretation of GeneChip data. Nucleic Acids Res 2005;33:e175.
10. Chi JT, Wang Z, Nuyten DS, et al. Gene expression programs in response to hypoxia: cell type specificity and prognostic significance in human cancers. PLoS Med 2006;3:e47.
11. Crawley JJ, Furge KA. Identification of frequent cytogenetic aberrations in hepatocellular carcinoma using gene expression data. Genome Biol 2002;3:RESEARCH0075.
12. Lindvall C, Furge KA, Bjorkholm M, et al. Combined genetic- and transcriptional profiling of acute myeloid leukemia with complex and normal karyotypes. Haematologia (Budap) 2004;89:1072-81.
13. Kim S, Volsky DJ. PAGE: parametric analysis of gene set enrichment. BMC Bioinformatics 2005;6:144.
14. Smyth GK . Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol [electronic resource] 2004;3:Article3.
15. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approachto multiple testing. J Roy Stat Soc B 1995;57:289-300.
16. Tretiakova M, Turkyilmaz M, Grushko T, et al. Topoisomerase IIα in Wilms' tumour: gene alterations and immunoexpression. J Clin Pathol 2006;59:1272-7.
17. Sandberg R, Ernberg I. Assessment of tumor characteristic gene expression in cell lines using a tissue similarity index (TSI). Proc Natl Acad Sci U S A 2005;102:2052-7.
18. Hurst CD, Tomlinson DC, Williams SV, Platt FM, Knowles MA. Inactivation of the Rb pathway and overexpression of both isoforms of E2F3 are obligate events in bladder tumours with 6p22 amplification. Oncogene. Epub 2007 Nov 27.